PortfoliosLab logoPortfoliosLab logo
FSHCX vs. SHPAX
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FSHCX vs. SHPAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity Select Health Care Services Portfolio (FSHCX) and Saratoga Health & Biotechnology Fund (SHPAX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FSHCX achieves a 10.58% return, which is significantly higher than SHPAX's 0.05% return. Over the past 10 years, FSHCX has outperformed SHPAX with an annualized return of 9.25%, while SHPAX has yielded a comparatively lower 6.73% annualized return.


FSHCX

1D
1.13%
1M
6.00%
YTD
10.58%
6M
10.93%
1Y
16.00%
3Y*
2.05%
5Y*
1.70%
10Y*
9.25%

SHPAX

1D
0.76%
1M
-0.84%
YTD
0.05%
6M
-1.21%
1Y
16.81%
3Y*
7.07%
5Y*
4.68%
10Y*
6.73%
*Multi-year figures are annualized to reflect compound growth (CAGR)

FSHCX vs. SHPAX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FSHCX
Fidelity Select Health Care Services Portfolio
10.58%3.85%-13.21%1.52%0.86%20.22%18.58%19.91%10.17%24.46%
SHPAX
Saratoga Health & Biotechnology Fund
0.05%17.43%0.26%-0.36%1.93%16.71%3.52%27.67%-5.30%11.78%

Correlation

The correlation between FSHCX and SHPAX is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.60

Correlation (3Y)
Calculated over the trailing 3-year period

0.65

Correlation (5Y)
Calculated over the trailing 5-year period

0.74

Correlation (10Y)
Calculated over the trailing 10-year period

0.76

Correlation (All Time)
Calculated using the full available price history since Jan 3, 2000

0.70

The correlation between FSHCX and SHPAX shifts across timeframes, from 0.60 (1 year) to 0.76 (10 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FSHCX vs. SHPAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FSHCX
FSHCX Risk / Return Rank: 1010
Overall Rank
FSHCX Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
FSHCX Sortino Ratio Rank: 99
Sortino Ratio Rank
FSHCX Omega Ratio Rank: 1111
Omega Ratio Rank
FSHCX Calmar Ratio Rank: 1010
Calmar Ratio Rank
FSHCX Martin Ratio Rank: 99
Martin Ratio Rank

SHPAX
SHPAX Risk / Return Rank: 2121
Overall Rank
SHPAX Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
SHPAX Sortino Ratio Rank: 2020
Sortino Ratio Rank
SHPAX Omega Ratio Rank: 1818
Omega Ratio Rank
SHPAX Calmar Ratio Rank: 2727
Calmar Ratio Rank
SHPAX Martin Ratio Rank: 1919
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FSHCX vs. SHPAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Health Care Services Portfolio (FSHCX) and Saratoga Health & Biotechnology Fund (SHPAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FSHCXSHPAXDifference
Sharpe ratioReturn per unit of total volatility

-0.38

Sortino ratioReturn per unit of downside risk

-0.63

Omega ratioGain probability vs. loss probability

1.16

1.20

-0.04

Calmar ratioReturn relative to maximum drawdown

0.95

1.82

-0.87

Martin ratioReturn relative to average drawdown

2.40

4.51

-2.11

FSHCX vs. SHPAX - Sharpe Ratio Comparison

The current FSHCX Sharpe Ratio is 0.78, which is lower than the SHPAX Sharpe Ratio of 1.16. The chart below compares the historical Sharpe Ratios of FSHCX and SHPAX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FSHCX vs. SHPAX - Drawdown Comparison

The maximum FSHCX drawdown since its inception was -57.81%, smaller than the maximum SHPAX drawdown of -69.50%. Use the drawdown chart below to compare losses from any high point for FSHCX and SHPAX.


Loading charts...

Drawdown Indicators


FSHCXSHPAXDifference

Max Drawdown

Largest peak-to-trough decline

-57.81%

-69.50%

+11.69%

Max Drawdown (1Y)

Largest decline over 1 year

-17.15%

-9.33%

-7.82%

Max Drawdown (3Y)

Largest decline over 3 years

-29.52%

-16.32%

-13.20%

Max Drawdown (5Y)

Largest decline over 5 years

-29.52%

-16.32%

-13.20%

Max Drawdown (10Y)

Largest decline over 10 years

-35.48%

-28.05%

-7.43%

Current Drawdown

Current decline from peak

-5.37%

-5.88%

+0.51%

Average Drawdown

Average peak-to-trough decline

-11.36%

-27.88%

+16.52%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.75%

3.75%

+3.00%

Volatility

FSHCX vs. SHPAX - Volatility Comparison

Fidelity Select Health Care Services Portfolio (FSHCX) and Saratoga Health & Biotechnology Fund (SHPAX) have volatilities of 5.16% and 5.14%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FSHCXSHPAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.16%

5.14%

+0.02%

Volatility (6M)

Calculated over the trailing 6-month period

15.47%

10.44%

+5.03%

Volatility (1Y)

Calculated over the trailing 1-year period

20.77%

14.64%

+6.13%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.24%

14.34%

+4.90%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

21.51%

16.62%

+4.89%

FSHCX vs. SHPAX - Expense Ratio Comparison

FSHCX has a 0.71% expense ratio, which is lower than SHPAX's 2.90% expense ratio.


Dividends

FSHCX vs. SHPAX - Dividend Comparison

FSHCX's dividend yield for the trailing twelve months is around 0.68%, less than SHPAX's 3.66% yield.


PositionTTM20252024202320222021202020192018201720162015
FSHCX
Fidelity Select Health Care Services Portfolio
0.68%0.75%16.63%0.57%5.32%7.09%0.76%0.27%12.92%13.41%4.62%4.06%
SHPAX
Saratoga Health & Biotechnology Fund
3.66%3.66%1.35%5.38%6.34%3.76%13.82%13.24%22.00%17.98%12.52%10.70%

Frequently Asked Questions


FSHCX and SHPAX have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FSHCX has higher volatility (5.16%) compared to SHPAX (5.14%). In terms of maximum drawdown, FSHCX dropped -57.81% vs SHPAX's -69.50%.

SHPAX currently has the higher Sharpe Ratio (1.16 vs 0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FSHCX and SHPAX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer